Northern Trust Corp Intercept Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.99 - $18.71 $1.06 Million - $1.99 Million	106,216 Added 38.33%	383,323 $7.11 Million
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $45,070 - $94,810	4,915 Added 1.81%	277,107 $3.06 Million
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $40,058 - $69,406	3,197 Added 1.19%	272,192 $3.66 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $243,577 - $337,987	20,980 Added 8.46%	268,995 $3.33 Million
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $7,228 - $11,662	-592 Reduced 0.24%	248,015 $3.46 Million

Q2 2022 Aug 12, 2022	SELL	$11.23 - $19.59 $181,420 - $316,476	-16,155 Reduced 6.1%	248,607 $3.43 Million
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $178,957 - $238,119	-13,385 Reduced 4.81%	264,762 $4.31 Million
Q4 2021 Feb 08, 2022	SELL	$14.28 - $19.53 $100,773 - $137,823	-7,057 Reduced 2.47%	278,147 $4.53 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $194,888 - $307,111	-15,003 Reduced 5.0%	285,204 $4.24 Million
Q2 2021 Aug 13, 2021	BUY	$15.46 - $24.5 $214,368 - $339,717	13,866 Added 4.84%	300,207 $6 Million
Q1 2021 May 12, 2021	SELL	$19.33 - $37.75 $235,632 - $460,172	-12,190 Reduced 4.08%	286,341 $6.61 Million
Q4 2020 Feb 11, 2021	SELL	$24.48 - $42.47 $217,749 - $377,770	-8,895 Reduced 2.89%	298,531 $7.37 Million
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $1.34 Million - $1.84 Million	-34,341 Reduced 10.05%	307,426 $12.7 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $306,538 - $604,150	6,564 Added 1.96%	341,767 $16.4 Million
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $172,416 - $423,212	3,566 Added 1.08%	335,203 $21.1 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $182,404 - $394,638	-3,180 Reduced 0.95%	331,637 $41.1 Million
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $2.41 Million - $3.3 Million	41,041 Added 13.97%	334,817 $22.2 Million
Q2 2019 Aug 13, 2019	BUY	$77.77 - $120.68 $1.81 Million - $2.81 Million	23,309 Added 8.62%	293,776 $23.4 Million
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $441,334 - $579,988	4,806 Added 1.81%	270,467 $30.3 Million
Q4 2018 Feb 12, 2019	SELL	$85.79 - $126.46 $147,558 - $217,511	-1,720 Reduced 0.64%	265,661 $26.8 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $851,804 - $1.23 Million	9,626 Added 3.73%	267,381 $33.8 Million
Q2 2018 Sep 18, 2018	SELL	$60.0 - $85.67 $200,940 - $286,908	-3,349 Reduced 1.28%	257,755 $21.6 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $10.3 Million - $14.8 Million	172,304 Added 194.04%	261,104 $21.9 Million
Q1 2018 May 09, 2018	BUY	$52.72 - $67.25 $131,220 - $167,385	2,489 Added 2.88%	88,800 $5.46 Million
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $10,592 - $13,242	182 Added 0.21%	86,311 $5.04 Million
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $4.91 Million - $10.2 Million	86,129	86,129 $5 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account